SMTI Earnings Date & History
Sanara Medtech Inc (NASDAQ NMS - GLOBAL MARKET) earnings schedule, consensus estimates and reported results for the last eight quarters.
Last updated Aug 19, 2026 at 4:08 PM ET
Sanara Medtech Inc
Health Care
- Next earnings date
- Tuesday, November 10, 2026
- Reporting session
- Time TBD
- EPS estimate
- $0.04
- Revenue estimate
- $30.5M
SMTI earnings history
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| Monday, May 11, 2026 | Q1 2026 | $-0.13 | $0.05 | +137.7% | $27.8M |
| Tuesday, March 24, 2026 | Q4 2025 | $0.11 | $0.09 | -19.8% | $27.5M |
| Wednesday, November 12, 2025 | Q3 2025 | $-0.22 | $0.09 | +141.0% | $26.3M |
| Wednesday, August 13, 2025 | Q2 2025 | $-0.45 | $-0.23 | +48.8% | $25.8M |
What the market is watching in SMTI's next report
- The full Earnings Read for this company: focus areas, peer read-through and prior-reaction context.
- Ticker Read combines trend, relative strength and catalysts in one research view.
- Scanners, Impact Radar and the members-only Weekly Watchlist are included.
Get the week's earnings by email
One free email each week: the reports that matter, when they land, and what the market is watching.
Frequently asked questions
- When is the next SMTI earnings date?
- Sanara Medtech Inc is scheduled to report on Tuesday, November 10, 2026 (Time TBD). Dates can change until the company confirms them.
- Does SMTI report before or after the market?
- The next report is scheduled time tbd.
- What EPS is expected for SMTI?
- Consensus EPS for the upcoming quarter is $0.04, on revenue of $30.5M.
Calendar data is provided for educational and research purposes only and is not investment advice. Release dates, times, estimates and results can change; always verify against the issuing company or agency.
SMTI earnings discussion
Anyone can read. Any free Hyper Stocks account can join in.
Create a free account to join the discussion. Reading is open to everyone — commenting is free, no subscription needed.
Loading discussion…
Member comments are opinions from individual users, not Hyper Stocks research, and are never personalised investment advice.